ClinicalTrials.gg
WithdrawnNCT01026961Updated Mar 3, 2016

Safety of Phenylephrine Hydrochloride, Acetaminophen, Dimethindene Maleate Compared to Phenylephrine Hydrochloride Alone in Healthy Volunteers

A Phase 1/2 interventional study of Phenylephrine HCL and Phenylephrine HCL/Acetaminophen/Dimethindene Maleate in Heart Rate, Blood Pressure and Arrhythmias, sponsored by Novartis. Withdrawn at 1 site in Brazil. Open to participants aged 18 Years to 50 Years. Per ClinicalTrials.gov, last updated 2016-03-03.

Sponsored by Novartis · Phase 1/2 and Interventional

Why this study was withdrawn
Study is no longer required by Brazil health authority.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 1/2
Study type
Interventional
Enrollment
0
Allocation
Randomized
Ages
18 Years to 50 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-19

Among 29 studies in Arrhythmias, Cardiac with a site in Brazil — 3 open to participants now, 4 under way, none of them phase 3. Arrhythmias, Cardiac · Brazil.

Enrollment
19th of 20
0 · median 65
Started
2010
the only one that year
Phase 1/2
2 of 29
none open now
Registered
6th of 29
by date

Among the 29 studies in Arrhythmias, Cardiac with a site in Brazil, this one is the 19th largest by enrollment of the 20 interventional ones that give a count, is the only one that started in 2010, is one of 2 in phase 1/2, and was the 6th registered.

Arrhythmias, Cardiac

1,051 studies on the registry are indexed under Arrhythmias, Cardiac; 235 are open to participants now.

Browse Arrhythmias, Cardiac studies →

Open to participants now

3 of the 29 studies in Arrhythmias, Cardiac with a site in Brazil are open now. Recruiting first, the newest first:

All 3 open studies →

A study can be open while its sites in Brazil have not opened yet or have stopped. Only those recruiting at a site in Brazil →

Who these studies take

Of the 166 Arrhythmias, Cardiac studies recruiting now, 118 (71%) set no upper age limit and 13 (8%) stop at 75 or younger; 31 take children under 18; 26 take healthy volunteers.

This study: 18 Years to 50 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 29 studies in Arrhythmias, Cardiac with a site in Brazil, or all of them as a file.
02

Study summary

This study will evaluate the safety of phenylephrine hydrochloride 10 mg + acetaminophen 500 mg + dimethindene maleate 1 mg compared to phenylephrine hydrocloride 10 mg alone in healthy volunteers.

03

Conditions studied

  • Heart Rate
  • Blood Pressure
  • Arrhythmias

Keywords

  • Safety
  • heart rate
  • systolic and diastolic blood pressure
  • arrhythmias
04

Who can participate

Ages eligible
18 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Healthy volunteers between 18 and 50 years;
  • Clinical examination without abnormal findings
  • Ability to understand the nature and purpose of the study, including the risks and adverse effects

Exclusion criteria

Exclusion Criteria:

  • Any cardiovascular disease, coronary artery disease, circulation problems or history of stroke, peripheral vascular disease or arrhythmia
  • History of serious adverse reactions or any drug
  • Hypersensitivity to the drug study drugs or chemically related compounds
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Hypersensitivity

An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.

05

Study design

Phase
Phase 1 / Phase 2
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Triple (Participant, Care provider, Investigator)
Enrollment
0 participants (actual)

Study arms

  • Experimental
    Phenylephrine HCL/Acetaminophen/Dimethindene Maleate

    Phenylephrine HCL/Acetaminophen/Dimethindene Maleate

    Drug: Phenylephrine HCL/Acetaminophen/Dimethindene Maleate

  • Active comparator
    Phenylephrine hydrochloride

    Phenylephrine hydrochloride 10mg

    Drug: Phenylephrine HCL

Interventions

06

What researchers measure

Primary outcomes

  1. To compare the effect of phenylephrine hydrochloride 10mg + acetaminophen 500mg + dimethindene maleate 1mg and phenylephrine hydrochloride 10mg alone on vital signs

    Time frame: 15 days

Secondary outcomes

  1. Electrocardiographic (ECG) monitoring and evaluation of heart rhythm following dosing

    Time frame: 15 days

  2. To report and evaluate adverse events

    Time frame: 15 days

07

Study locations

1 site
  • Scentryphar Pesquisa Clinica Ltda.
    Campinas, São Paulo, Brazil
08

References and documents

Related links

09

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Sep 2010 and a primary completion of Nov 2010. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 4, 2009
First posted
Dec 7, 2009
Start
Sep 2010
Primary completionEst.
Nov 2010
Last update
Mar 3, 2016
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 3, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01026961
Lead sponsor
Novartis
First posted
Dec 7, 2009
Start date
Sep 2010
Primary completion
Nov 2010 (estimated)
Last update
Mar 3, 2016

Study contacts

Novartis Biociências S.A
study director · Novartis

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in Mar 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drugs tested here: Phenylephrine · Acetaminophen · Dimethindene

Start the discussion